Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407

Acta Pharmaceutica

Volumn 59, Issue 4, 2009, Pages 453-461

  Vyas, Vikrant ^a   Sancheti, Pankajkumar ^a   Karekar, Poonam ^a   Shah, Manali ^a   Pore, Yogesh ^a  

^a Department of Applied Mechanicsg Government College of Engineering   (India)

Author keywords

Dissolution; Poloxamer 407; Solid dispersion; Tadalafil

Indexed keywords

POLOXAMER; TADALAFIL;

ARTICLE; DISSOLUTION; FLOW KINETICS; HYDROGEN BOND; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; X RAY POWDER DIFFRACTION;

EID: 77949446521     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0037-4     Document Type: Article

References (15)

1. D. A. Hussar, New drugs of 2003, J. Am. Pharm. Assoc. 44 (2004) 168-206; DOI: 10.1331/ 154434504773062627.
2. H. Porst, H. Padma-Nathan, F. Giuliano, G. Anglin, L. Varanese and R. Rosen, Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial, Urology 62 (2003) 121-125; DOI: 10.1016/S0090-4295(03)00359-5.
3. H. Schott, L. C. Kwan and S. Feldman, The role of surfactant in the release of very slightly soluble drugs from tablets, J. Pharm. Sci. 71 (1982) 1038-1045; DOI: 10.1002/jps.2600710921.
4. F. Veiga, J. J. C. Teixeria-Dias, F. Kedzeierewicz, A. Sousa and P. Maincent, Inclusion complexation of tolbutamide with b-cyclodextrin and hydroxypropyl-b-cyclodextrin, Int. J. Pharm. 129 (1996) 63-71; DOI: 10.1016/0378-5173(95)04243-1.
5. J. O. Henck, U. J. Griesser and A. Burger, Polymorphie von Arzneistoffen eine wirtschaftliche Herausforderung?, Pharm. Ind. 59 (1997) 165-169.
6. L. Christian and J. Dressman, Improving drug solubility for oral delivery using solid dispersions, Eur. J. Pharm. Biopharm. 50 (2000) 47-60; DOI: 10.1016/S0939-6411(00)00076-X.
7. D. Q. M. Craig, The mechanisms of drug release from solid dispersions in water-soluble polymers, Int. J. Pharm. 231 (2002) 131-144; DOI: 10.1016/S0378-5173(01)00891-2.
8. M. Newa, K. H. Bhandari, D. X. Li, T. H. Kwon, J. A. Kim, B. K. Yoo, J. S. Woo, W. S. Lyoo, C. S. Yong and H. G. Choi, Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188, Int. J. Pharm. 343 (2007) 228-237; DOI: 10.1016/j.ijpharm. 2007.05.031.
9. G. Dumortier, J. L. Grossiord, F. Agnely and J. C. Chaumeil, A review of poloxamer 407 pharmaceutical and pharmacological characteristics, Pharm. Res. 23 (2006) 2709-2728; DOI: 10.1007/ s11095-006-9104-9114
10. D. S. Singhare, S. Khan and P. G. Yeole, Poloxamers: Promising block co-polymers in drug delivery, Indian J. Pharm. Sci. 67 (2005) 523-531.
11. J. L. Ford, The current status of solid dispersions, Pharm. Acta Helv. 61 (1986) 69-88.
12. J. A. Ryan, Compressed pellet X-ray diffraction monitoring for optimisation of crystallinity in lyophilised solids: imipenem: cilastatin sodium case, J. Pharm. Sci. 75 (1986) 805-807; DOI: 10.1002/ jps.2600750817.
13. Y. J. Park, C. S. Yong, H. M. Kim, J. D. Rhee, Y. K. Oh, C. K. Kim and H. G. Choi, Effect of sodium chloride on the release, absorption and safety of diclofenac sodium delivered by poloxamer gel, Int. J. Pharm. 263 (2003) 105-111; DOI: 10.1016/S0378-5173(03)00362-4.
14. G. Mooter, P. Augustijns, N. Blaton and R. Kinget, Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30, Int. J. Pharm. 164 (1998) 67-80; DOI: 10.1016/S0378-5173(97)00401- 8.
15. T. Save and P. Venkitachalam, Studies on solid dispersions of nifedipine, Drug Dev. Ind. Pharm. 18 (1992) 1663-1679; DOI: 10.3109/03639049209040893.